Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TetraGenx

TetraGenx
2000 FOUNDED
M&A STATUS
21-30 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of multiple services intended for the animal pharmaceutical industry. The company's services include product development, analytical testing, manufacturing to support the animal health industry by specializing in complex drug product formulation development to create innovative pharmaceutical, over-the-counter and nutraceutical veterinary pharma products.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare
Pharmaceuticals
Parent Company
Primary Office
  • 9622 Trans Canada Highway
  • Saint Laurent, Quebec H4S 1V9
  • Canada

+1 (514) 000-0000

TetraGenx Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore TetraGenx‘s full profile, request access.

Request full access to PitchBook

TetraGenx Executive Team (1)

Name Title Board
Seat
Contact
Info
Kevin McDonnell Founder, President & Director of Pharma